Use of genetic toxicology information for risk assessment

Environmental and Molecular Mutagenesis

Volumn 46, Issue 4, 2005, Pages 236-245

  Dearfield, Kerry L ^a,c   Moore, Martha M ^b,d  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c U S DEPARTMENT OF AGRICULTURE   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Genetic toxicology; Mutagenic mode of action; Risk assessment

Indexed keywords

CARCINOGEN; DRUG; PESTICIDE;

CYTOGENETICS; DECISION MAKING; DEVICE; ENVIRONMENTAL EXPOSURE; FOOD AND DRUG ADMINISTRATION; FOOD CONTAMINATION; GENETIC TOXICOLOGY; GERM CELL; GOVERNMENT; HEALTH HAZARD; MUTAGENICITY; REGISTRATION; REVIEW; RISK ASSESSMENT; SOMATIC MUTATION;

ANIMALS; DATABASES, GENETIC; DECISION SUPPORT TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MUTAGENICITY TESTS; MUTAGENS; RISK ASSESSMENT; SOFTWARE DESIGN; TOXICOLOGY;

EID: 30844437463     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20176     Document Type: Review

References (46)

1. Aidoo A, Morris SM, Casciano DA. 1997. Development and utilization of the rat lymphocyte hprt mutation assay. Mutat Res 387:69-88.
2. Albertini RJ, Nicklas JA, O'Neill JP. 1993. Somatic cell gene mutations in humans: biomarkers for genotoxicity. Environ Health Perspect 101(Suppl 3):193-201.
3. Ames BN, McCann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347-364.
4. Applegate ML, Moore MM, Broder CB, Burrell A, Hozier JC. 1990. Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci USA 87:51-55.
5. Brusick D. 1986. Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ Mutagen 8:879-886.
6. Burkhart JG, Burkhart BA, Sampson KS, Malling HV. 1993. ENU-induced mutagenesis at a single A:T base pair in transgenic mice containing φ X174. Mutat Res 292:69-81.
7. +/- -3.7.2C mouse lymphoma cells. Mutagen 17:105-109.
8. Cimino MC. 2001. New OECD genetic toxicology guidelines and interpretation of results. In: Choy WN, editor. Genetic Toxicology and Cancer Risk Assessment. New York: Marcel Dekker, pp 223-248.
9. +/- 3.7.2C mouse lymphoma cells. Mutagen 13:427-434.
10. Clewell HJ, III, Andersen ME, Barton HA. 2002. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environ Health Perspect 110:85-93.
11. Clive D, Spector JF. 1975. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutat Res 31:17-29.
12. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM). 2000. Guidance on a Strategy for Testing of Chemicals for Mutagenicity. London: Department of Health. Available at http://www. advisorybodies.doh.gov.uk/Com/guidance.pdf.
13. Dearfield KL, Auletta AE, Cimino MC, Moore MM. 1991. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat Res 258:259-283.
14. Dearfield KL, McCarroll NE, Protzel A, Stack HF, Jackson MA, Waters MD. 1999. A survey of EPA/OPP and open literature on selected pesticide chemicals. II. Mutagenicity and carcinogenicity of selected chloroacetanilides and related compounds. Mutat Res 443: 183-221.
15. Dearfield KL, Cimino MC, McCarroll NE, Mauer I, Valcovic LR. 2002. Genotoxicity risk assessment: a proposed classification strategy. Mutat Res 521:121-135.
16. +/- embryonic stem cell line for use in mutagenicity studies. Environ Mol Mutagen 28:483-489.
17. Dycaico MJ, Provost GS, Kretz PL, Ransom SL, Moores JC, Short JM. 1994. The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat Res 307:461-478.
18. Fenech M, Morley AA. 1989. Kinetochore detection in micronuclei: an alternative method for measuring chromosome loss. Mutagen 4: 98-104.
19. Galloway SM. 2000. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case of an upper limit on toxicity in the aberration assay. Environ Mol Mutagen 35:191-201.
20. Gossen JA, de Leeuw WJ, Tan CH, Zwarthoff EC, Berends F, Lohman PH, Knook DL, Vijg J. 1989. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci USA 86:7971-7975.
21. Grant SG. 2005. The GPA in vivo somatic mutation assay. Methods Mol Biol 291:179-195.
22. Hanks S, Coleman K, Reid S, Plaja A, Firth H, FitzPatrick D, Kidd A, Méhes K, Nash R, Robin N, Shannon N, Tolmie J, Swansbury J, Irrthum A, Douglas J, Rahman N. 2004. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36:1159-1161.
23. Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW, Salamone MF. 1983. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 123:61-118.
24. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 1995. S2A: guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. Available at http://www.ich.org/UrlGrpServer. jser?@_ID=276&@_TEMPLATE=254.
25. International Programme on Chemical Safety (IPCS). 1999. IPCS Workshop on Developing a Conceptual Framework for Cancer Risk Assessment, Lyon, France, February 16-18, 1999. IPCS/99.6. Geneva: World Health Organization.
26. Jacobson-Kram D, Jacobs A. 2005. Use of genotoxicity data to support clinical trials or positive genetox findings on a candidate pharmaceutical or impurity ... now what? Int J Toxicol 24:129-134.
27. Jakubczak JL, Merlino G, French JE, Muller WJ, Paul B, Adhya S, Garges S. 1996. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage λ transgene target. Proc Natl Acad Sci USA 93:9073-9078.
28. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M, Jr., Lorge E, Norppa H, Surralles J, von der Hude W, Wakata A. 2000. Report from the in vitro micronucleus assay working group. Environ Mol Mutagen 35:167-172.
29. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M, Jr., Kirchner S, Lorge E, Morita T, Norppa H, Surralles J, Vanhauwaert A, Wakata A. 2003. Report from the in vitro micronucleus assay working group. Mutat Res 540:153-163.
30. Levin DE, Hollstein M, Christman MF, Schwiers EA, Ames BN. 1982a. A new Salmonella tester strain (TA102) with AXT base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci USA 79:7445-7449.
31. Levin DE, Yamasaki E, Ames BN. 1982b. A new Salmonella tester strain, TA97, for the detection of frameshift mutagens. A run of cytosines as a mutational hot-spot. Mutat Res 94:315-330.
32. McCarroll NE, Protzel A. Ioannou Y, Stack HF, Jackson MA, Waters MD, Dearfield KL. 2002. A survey of EPA/OPP and open literature on selected pesticide chemicals. III. Mutagenicity and carcinogenicity of benomyl and carbendazim. Mutat Res 512:1-35.
33. Moore MM, Harrington-Brock K. 2000. Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene. Environ Health Perspect 108(Suppl 2):215-223.
34. Moore MM, Harrington-Brock K, Doerr CL, Dearfield KL. 1989. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagen 4:394-403.
35. Moore MM, Honma M, Clements J, Harrington-Brock K, Awogi T, Bolcsfoldi G, Cifone M, Collard D, Fellows M, Flanders K, Gollapudi B, Jenkinson P, Kirby P, Kirchner S, Kraycer J, McEnaney S, Muster W, Myhr B, O'Donovan M, Oliver J, Ouldelhkim MC, Pant K, Preston R, Riach C, San R, Shimada H, Stankowski LF, Jr. 2002. Mouse lymphoma thymidine kinase gene mutation assay: follow-up international workshop on genotoxicity test procedures, New Orleans. Louisiana, April 2000. Environ Mol Mutagen 40:292-299.
36. Müller L, Blakey D, Dearfield KL, Galloway S, Guzzie P, Hayashi M, Kasper P, Kirkland D, MacGregor JT, Parry JM, Schechtman L, Smith A, Tanaka N, Tweats D, Yamasaki H. 2003. Strategy for genotoxicity testing and stratification of genotoxicity test results - report on initial activities of the IWGT Expert Group. Mutat Res 540:177-181.
37. Organization for Economic Cooperation and Development (OECD). 1998. OECD Guidelines for the Testing of Chemicals. Paris: OECD. Available at www.oecd.org.
38. Parsons BL, Culp S, Manjanatha M, Heflich RH. 2002. Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression. Carcinogenesis 23:943-948.
39. Parsons BL, McKinzie PB, Heflich RH. 2005. Detection of rare base substitution. In: Keohavong P, Grant S, editors. Molecular Toxicology Protocols (Methods in Molecular Biology, Vol. 291). Totawa, NJ: Humana Press, pp 235-245.
40. Preston RJ, Au W, Bender MA, Brewen JG, Carrano AV, Heddle JA, McFee AF, Wolff S, Wassom JS. 1981. Mammalian in vivo and in vitro cytogenetic assays: a report of the U.S. EPA's Gene-Tox Program. Mutat Res 87:143-188.
41. US Environmental Protection Agency (USEPA). 1986. Guidelines for Mutagenicity Risk Assessment. Federal Register 51:34006-34012.
42. US Environmental Protection Agency (USEPA). 1991. Pesticide Assessment Guidelines, Subdivision F, Hazard Evaluation: Human and Domestic Animals, Series 84, Mutagenicity, Addendum 9. Washington, DC: Office of Pesticide Programs, USEPA. EPA Publication No. 540/09-91-122.
43. US Environmental Protection Agency (USEPA). 1998. OPPTS Harmonized Test Guidelines, Series 870, Health Effects Test Guidelines - Final Guidelines. Washington, DC: Office of Prevention, Pesticides and Toxic Substances. EPA Publication No. EPA/712/C-98/212. Available at http://www.epa.gov/opptsfrs/ OPPTS_Harmonized/870_Health_Effects_ Test_Guidelines/Series/.
44. US Environmental Protection Agency (USEPA). 2004. Potential Implications of Genomics for Regulatory and Risk Assessment Applications at EPA. Washington, DC: Science Policy Council, USEPA. EPA Publication No. EPA 100/B-04/002.
45. US Environmental Protection Agency (USEPA). 2005. Guidelines for Carcinogen Risk Assessment. Washington, DC: Risk Assessment Forum, USEPA. EPA Publication No. EPA/630/P-03/001F.
46. US Food and Drug Administration (USFDA). 2000. Redbook 2000. Toxicological Principles for the Safety Assessment of Food Ingredients. Washington, DC: Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, USFDA. Available at http://www. cfsan.fda.gov/~redbook/red- toca.html (Last updated April 2004).